Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Histone Deacetylase Inhibitor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02836548
What this trial is testing

HDAC Inhibitor Vorinostat in Resistant BRAF V600 Mutated Advanced Melanoma

Who this might be right for
MelanomaSkin Neoplasms
The Netherlands Cancer Institute 33
Testing effectiveness (Phase 2)Ended earlyNCT03233724
What this trial is testing

Oral Decitabine and Tetrahydrouridine as Epigenetic Priming for Pembrolizumab-Mediated Immune Checkpoint Blockade in Patients With Inoperable, or Unresectable Locally Advanced or Metastatic Non-Small Cell Lung Cancers and Esophageal Carcinomas

Who this might be right for
Carcinoma, Non-Small-Cell LungLung CancerNon-Small Cell Lung Cancer+2 more
National Cancer Institute (NCI) 9
Testing effectiveness (Phase 2)Ended earlyNCT00490776
What this trial is testing

Study of Oral LBH589 in Adult Participants With Refractory/Resistant Cutaneous T-Cell Lymphoma (CTCL)

Who this might be right for
Cutaneous T-Cell Lymphoma
Novartis Pharmaceuticals 9
Testing effectiveness (Phase 2)Study completedNCT00589290
What this trial is testing

Belinostat (PXD101) to Treat Tumors of the Thymus at an Advanced Stage

Who this might be right for
ThymomaThymic Carcinoma
National Cancer Institute (NCI) 41
Early research (Phase 1)Study completedNCT01464112
What this trial is testing

A Dose Escalation Study of the Histone Deacetylase Inhibitor (HDACi) JNJ 26481585 in Combination With VELCADE (Bortezomib) and Dexamethasone for Patients With Relapsed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC 18
Testing effectiveness (Phase 2)Ended earlyNCT00699296
What this trial is testing

Study of Oral LBH589 in Patients With Cutaneous T-cell Lymphoma and Adult T-cell Leukemia/Lymphoma

Who this might be right for
Cutaneous T-Cell LymphomaLeukemia-Lymphoma, Adult T-Cell
Novartis Pharmaceuticals 4
Early research (Phase 1)Study completedNCT01742988
What this trial is testing

Study to Assess the Safety, Tolerability and Pharmacokinetics of Fimepinostat (CUDC-907) in Patients With Lymphoma

Who this might be right for
LymphomaRelapsed LymphomaRefractory Lymphoma+8 more
Curis, Inc. 106
Testing effectiveness (Phase 2)UnknownNCT01305499
What this trial is testing

A Trial to Evaluate Two Schedules of MS275 in Combination With 5AC in Elderly Patients With Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia
Hetty Carraway 52
Large-scale testing (Phase 3)WithdrawnNCT03010865
What this trial is testing

Sodium Butyrate For Improving Cognitive Function In Schizophrenia

Who this might be right for
Schizophrenic DisorderCognitive Impairment
Shanghai Mental Health Center
Testing effectiveness (Phase 2)Ended earlyNCT01090973
What this trial is testing

Oral LBH589 in Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) and Mantle Cell Lymphoma (MCL)

Who this might be right for
Non-Hodgkin's Lymphoma
H. Lee Moffitt Cancer Center and Research Institute 1
Large-scale testing (Phase 3)UnknownNCT03564704
What this trial is testing

Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult T-LBL/ALL

Who this might be right for
LeukemiaLeukemia, AcuteAdult Lymphoblastic Lymphoma+5 more
Nanfang Hospital, Southern Medical University 80
Early research (Phase 1)Ended earlyNCT01159301
What this trial is testing

Entinostat and Sorafenib Tosylate in Treating Patients With Advanced or Metastatic Solid Tumors or Refractory or Relapsed Acute Myeloid Leukemia

Who this might be right for
Adult Acute Basophilic LeukemiaAdult Acute Eosinophilic LeukemiaAdult Acute Megakaryoblastic Leukemia (M7)+16 more
National Cancer Institute (NCI) 44
Not applicableStudy completedNCT03460444
What this trial is testing

The Effect of Raising Ketones Directly With MCT Oil on Inflammation in Healthy Young Adults

Who this might be right for
MCT Oil Supplementation
University of British Columbia 15
Testing effectiveness (Phase 2)UnknownNCT01298934
What this trial is testing

LBH589 (Panobinostat) for the Treatment of Myelofibrosis

Who this might be right for
Primary MyelofibrosisPolycythemia Vera, Post-Polycythemic Myelofibrosis PhasePost-Essential Thrombocythemia Related Myelofibrosis
Ronald Hoffman 22
Testing effectiveness (Phase 2)Ended earlyNCT00723203
What this trial is testing

Panobinostat in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia

Who this might be right for
Leukemia
City of Hope Medical Center 16
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06890585
What this trial is testing

Zanubrutinib, Chidamide, and Rituximab Induction With or Without CHOP Versus R-CHOP in Newly Diagnosed Double-Expressor DLBCL

Who this might be right for
BTK InhibitorsHistone Deacetylase InhibitorDouble Express Diffuse Large B-cell Lymphoma
Li Zhiming 128
Early research (Phase 1)Study completedNCT02922946
What this trial is testing

Study to Determine the Effect of the Timing of a Meal on the Pharmacokinetics of Entinostat

Who this might be right for
VolunteersHealthy VolunteersHuman Volunteers+1 more
Syndax Pharmaceuticals 47
Testing effectiveness (Phase 2)Study completedNCT00302159
What this trial is testing

Valproic Acid With Temozolomide and Radiation Therapy to Treat Brain Tumors

Who this might be right for
High Grade GliomasBrain Tumors
National Cancer Institute (NCI) 43
Testing effectiveness (Phase 2)Ended earlyNCT01282476
What this trial is testing

Panobinostat With Rituximab for Relapsed/Refractory Diffuse Large B Cell Lymphoma

Who this might be right for
Diffuse Large B Cell Lymphoma
Massachusetts General Hospital 18
Testing effectiveness (Phase 2)Study completedNCT00621244
What this trial is testing

Oral LBH589 in Adult Patients With Advanced Hematological Malignancies

Who this might be right for
LymphomaLeukemiaMultiple Myeloma
Novartis Pharmaceuticals 175
Next Page